Skip to content
Aminoscope
Head-to-head

Ashwagandha vs Rhodiola Rosea

Two adaptogens with genuinely different jobs: calming an over-revved stress response, versus holding mental performance together when you are already depleted.

By Julian RothResearch & dataUpdated October 2026

Short answer

Neither ashwagandha nor Rhodiola rosea needs a prescription, and both have human data, so the goal decides it. Ashwagandha is marketed for stress, sleep and testosterone; Rhodiola rosea is the choice for readers interested in stress, fatigue and focus. The table below compares their FDA status, route, headline human result and main safety signal side by side.

Ashwagandha

Withania somnifera

Clinical data

The best-studied adaptogen: multiple placebo-controlled RCTs for lowering stress and cortisol, decent sleep data, and a modest testosterone signal — with a rare but real liver-injury caveat.

Full Ashwagandha evidence review

Rhodiola Rosea

Clinical data

Several placebo-controlled RCTs show a short-term benefit for stress-related fatigue and mental performance — but trials are small/lower-quality and systematic reviews call it promising, not proven.

Full Rhodiola Rosea evidence review

Ashwagandha vs Rhodiola Rosea: head to head

FDA status / approved use

Ashwagandha

Sold as an herbal supplement

Rhodiola Rosea

Herbal adaptogen supplement; not a treatment for clinical depression or any diagnosed condition
Marketed for

Ashwagandha

Stress, sleep, testosterone

Rhodiola Rosea

Stress, fatigue, focus
Outcome areas

Ashwagandha

Mood / anxiety / stress; Sleep; Testosterone / male hormones

Rhodiola Rosea

Mood / anxiety / stress; Cognitive function / memory; Mitochondrial / cellular energy
Evidence grade

Ashwagandha

Clinical data

Rhodiola Rosea

Clinical data
How it works

Ashwagandha

Hormonal

Rhodiola Rosea

Adaptogen claimed to help the body resist stress; active markers rosavins and salidroside
Route and dosing

Ashwagandha

Oral standardized root extract, often taken twice daily with food

Rhodiola Rosea

Oral standardized extract, commonly 200 to 400 mg/day
Headline human result

Ashwagandha

Serum cortisol fell roughly a quarter to a third, with lower perceived stress, vs placebo in a 60-day 2012 RCT of 64 adults

Rhodiola Rosea

Greater fatigue reduction than placebo after 28 days of standardized SHR-5 extract in an RCT of adults with stress-related fatigue
Strongest evidence

Ashwagandha

RCT, Indian J Psychol Med 2012Ashwagandha evidence reviewPubMed 23439798

Rhodiola Rosea

Key safety signal

Ashwagandha

Rare but documented liver injury, usually 2 to 12 weeks after starting

Rhodiola Rosea

Mild dizziness, dry mouth or jitteriness; may interact with antidepressants, stimulants, blood-pressure or blood-sugar drugs
How it is obtained

Ashwagandha

Over the counter as a dietary supplement

Rhodiola Rosea

Over the counter as a dietary supplement

marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.

Clinical data:
Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).

Our verdict

Neither has been tested against the other, so this is a comparison across separate trials. Ashwagandha has the more reproducible signal for what most people want from an adaptogen: lower perceived stress and lower cortisol across several placebo-controlled trials of standardized extracts, plus supporting data on sleep. Rhodiola's niche is narrower and its trials are smaller; the SHR-5 extract reduced stress-related fatigue and helped night-duty physicians and exam-period students hold up cognitively, but the two major systematic reviews call the evidence promising rather than settled. Both effects belong to specific standardized extracts, not to generic capsules, and neither treats a clinical mood disorder; in one trial rhodiola improved depression less than sertraline, with fewer side effects.

Ashwagandha fits if

Someone whose main complaint is stress, anxiety, or poor sleep, and who will watch for the rare liver-injury signal and stop at the first sign of it.

Rhodiola Rosea fits if

Someone who is burned out and needs to think clearly through it, and who would rather take something mildly activating in the morning than something mildly sedating.

Ashwagandha vs Rhodiola Rosea: common questions

Is either ashwagandha or Rhodiola rosea FDA-approved?
No. Ashwagandha is sold as an herbal supplement. Rhodiola rosea is an herbal adaptogen supplement; not a treatment for clinical depression or any diagnosed condition.
Which has stronger human evidence, ashwagandha or Rhodiola rosea?
Neither clearly. Both have human clinical data. The key source for ashwagandha is RCT, Indian J Psychol Med 2012; for Rhodiola rosea, it is Olsson RCT, Planta Med 2009.
What are the main safety concerns with ashwagandha and Rhodiola rosea?
For ashwagandha, watch for rare but documented liver injury, usually 2 to 12 weeks after starting. For Rhodiola rosea, watch for mild dizziness, dry mouth or jitteriness; may interact with antidepressants, stimulants, blood-pressure or blood-sugar drugs.

Key studies behind each

Ashwagandha

  1. Chandrasekhar K, Kapoor J, Anishetty S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. PubMed 23439798
  2. Lopresti AL, Smith SJ, Malvi H, Kodgule R. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). PubMed 31517876
  3. Salve J, Pate S, Debnath K, Langade D. (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: A double-blind, randomized, placebo-controlled clinical study. Cureus. PubMed 32021735
  4. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. (2019). Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety: A double-blind, randomized, placebo-controlled study. Cureus. PubMed 31728244

Rhodiola Rosea

  1. Olsson EM, von Schéele B, Panossian AG. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. PubMed 19016404
  2. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. (2000). Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. PubMed 11081987
  3. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. PubMed 10839209
  4. Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. (2015). Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. PubMed 25837277

The full evidence reviews

Related comparisons